How pharmacists can keep up with biosimilar approvals
April 10th 2015The Food and Drug Administration (FDA) has released its lists of approved biosimilar licensed products, called the “Purple Book”. The invaluable site includes the date a biological product was licensed under the PHS Act and whether FDA evaluated the biological product for reference product exclusivity.
Technology use in hospital pharmacy increases
April 7th 2015Approximately one third of U.S. hospitals have completely migrated to the electronic health record (EHR) and are no longer using paper charts. In those hospitals with an EHR that they use completely or in combination with paper charts, 80% give pharmacists the ability to make recommendations and document them in the EHR.
BioCryst receives $12 million for Ebola drug development
March 31st 2015BioCryst Pharmaceuticals, Durham, North Carolina, was awarded a $12 million contract with the U.S. Department of Health and Human Services for the development and manufacture of its small molecule, BCX4430, for the prevention of Ebola virus reproduction.